Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP-SEPSIS: Aspirin in Sepsis
NCT01784159Phase 2Terminated
- Sponsor
- Federal University of São Paulo
- Start
- Mar 2019
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in sepsis, septic shock, sponsored by Federal University of São Paulo. Started Mar 2019; status: terminated.
02
Drugs
aspirin
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT01784159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01784159.